BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
BusinessActinium Pharmaceuticals to Sponsor 4th Annual Summit on Hematologic MalignanciesBy Nasdaq OMXMar 16, 2017, 9:30 PM UTC
BusinessPeregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2017 and Recent DevelopmentsBy Nasdaq OMXMar 13, 2017, 8:05 PM UTC
BusinessTesaro Announces Presentation of Niraparib Phase 3 ENGOT-OV16/NOVA Trial Secondary Endpoint Results During SGOBy Nasdaq OMXMar 13, 2017, 3:10 PM UTC
BusinessPeregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred StockBy Nasdaq OMXMar 9, 2017, 9:05 PM UTC
BusinessGenomOncology and med fusion announce the addition of PD-L1 Testing and Interpretation to the LungSEQ® and 50SEQ® Plus FISH TestsBy Nasdaq OMXMar 7, 2017, 2:00 PM UTC
